Publisher
Springer Nature Switzerland
Reference18 articles.
1. Organización Mundial de la Salud: OMS INDICADORES DE FARMACOVIGILANCIA: UN MANUAL PRÁCTICO PARA LA EVALUACIÓN DE LOS SISTEMAS DE FARMACOVIGILANCIA. Ginebra (2019). Accessed 02 Dec 2022. https://apps.who.int/iris/bitstream/handle/10665/325851/9789243508252-spa.pdf?ua=1
2. Lavertu, A., Hamamsy, T., Altman, R.B.: Quantifying the severity of adverse drug reactions using social media: network analysis. J. Med. Internet Res. 23(10), e27714 (2021). https://www.jmir.org/2021/10/e27714. https://doi.org/10.2196/27714
3. Chapman, A.B., Peterson, K.S., Alba, P.R., DuVall, S.L., Patterson, O.V.: Detecting adverse drug events with rapidly trained classification models. Drug Saf. 42(1), 147–156 (2019). https://doi.org/10.1007/S40264-018-0763-Y/TABLES/12
4. Alimova, I.S., Tutubalina, E.V.: Entity-level classification of adverse drug reaction: a comparative analysis of neural network models. Programm. Comput. Softw. 45(8), 439–447 (2020). https://doi.org/10.1134/S0361768819080024
5. Liu, Y., Shi, J., Chen, Y.: Patient-centered and experience-aware mining for effective adverse drug reaction discovery in online health forums. J. Assoc. Inf. Sci. Technol. 69(2), 215–228 (2018). https://doi.org/10.1002/ASI.23929